← All trials
NCT04619082
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2020
- Primary completion
- Dec 31, 2022
- Completion date
- Dec 31, 2023
- First posted
- Nov 6, 2020
- Last posted
- Nov 6, 2020
- Enrollment
- 150
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Chiayi Christian HospitalLead sponsor
- National Taiwan UniversityCollaborator
- Chimei Medical CenterCollaborator
- Dalin Tzu Chi General HospitalCollaborator
- Chiayi Christian HospitalOverall official - principal investigator
- St. Martin De Porress HospitalCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.